WEBVTT 1 00:00:00.200 --> 00:00:04.120 I was born in Iran, and when I was ten years old, the 2 00:00:04.240 --> 00:00:09.439 Islamic Revolution happened, and that sort of turned the world upside down for us. 3 00:00:10.320 --> 00:00:14.720 I came to the US when I was a teenager, and we lived 4 00:00:14.759 --> 00:00:17.519 in New York, and I went to school at the University of Buffalo, 5 00:00:17.640 --> 00:00:25.280 State University of New York at Buffalo studied car engineering and computer science, did 6 00:00:25.359 --> 00:00:31.199 my undergrad and graduate work there, and later on I went to University of 7 00:00:31.280 --> 00:00:36.399 Rochester and studied finance. You know, this is not going to surprise you. 8 00:00:36.679 --> 00:00:39.759 In this feature we have of CEOs as you know, whether it's a 9 00:00:39.840 --> 00:00:43.520 national one that we're doing today or one that I do locally for the Washington 10 00:00:43.600 --> 00:00:48.240 d C in the DMV area. It is amazing how many immigrants have come 11 00:00:48.280 --> 00:00:53.759 here at a young age and made so many wonderful things happen in our world 12 00:00:54.079 --> 00:01:00.320 and are now entrepreneurs and investors and CEOs. And I'm very lucky to talk 13 00:01:00.359 --> 00:01:03.879 to people like you, Omeed, because I love to see. You know 14 00:01:04.120 --> 00:01:08.079 what, America was supposed to be a melting pot of everybody from all over 15 00:01:08.079 --> 00:01:14.200 the world getting an opportunity and making something of those selves. We do want 16 00:01:14.239 --> 00:01:17.879 to talk about the lab a lot today and cancer screening obviously is a big 17 00:01:17.920 --> 00:01:19.439 deal. And I want to talk about technology, what the latest is, 18 00:01:19.480 --> 00:01:23.280 and what you're doing with everybody domestically in the US, because I think cancer 19 00:01:23.319 --> 00:01:27.879 and I know you would know this specifically, it's touched everybody either directly or 20 00:01:27.920 --> 00:01:33.159 indirectly when it comes to cancer and our families or experiencing ourselves. But I 21 00:01:33.159 --> 00:01:37.920 did want to talk about you before you came up with your company about five 22 00:01:38.000 --> 00:01:42.640 years ago. I know you're an inventor, you're an entrepreneur, venture investor, 23 00:01:42.719 --> 00:01:45.719 and also an educator. Tell us what you did before coming up with 24 00:01:45.760 --> 00:01:48.799 this company. Oh, A whole bunch of different things, you know. 25 00:01:48.879 --> 00:01:53.719 As I mentioned in my education, I started in engineering, and after graduate 26 00:01:53.760 --> 00:01:57.159 school, I went to work for Eastman Kodak, which was a very large 27 00:01:57.159 --> 00:02:02.959 company and working in many different fields at the time in Rochester, New York. 28 00:02:04.400 --> 00:02:07.840 And I worked for them in medical imaging, and that was the work 29 00:02:07.879 --> 00:02:12.759 that I was doing actually in graduate school with medical imaging, and I worked 30 00:02:12.759 --> 00:02:19.599 for Kodak in cardiac imaging and beginnings of all the digital technologies that now we're 31 00:02:19.680 --> 00:02:24.240 using every day in digital photography and imaging and all of those technologies were developed 32 00:02:24.240 --> 00:02:29.919 over those years in the early nineties at Kodak, and I was very fortunate 33 00:02:29.960 --> 00:02:34.039 to be working on a lot of those. I worked in different fields for 34 00:02:34.120 --> 00:02:38.039 them, for Kodak and cardiology. I even went in the field worked for 35 00:02:38.080 --> 00:02:44.840 them in Hollywood in sales and marketing and in anything from cell phone cameras to 36 00:02:45.000 --> 00:02:50.879 printers to the various technologies that are now all over the place. After Kodak 37 00:02:51.120 --> 00:02:54.599 went bankrupt and was licensed to everyone else. After that, I actually came 38 00:02:54.639 --> 00:02:58.599 to your nekad was I was a management consultant in Washington, d C. 39 00:02:58.719 --> 00:03:01.280 It was very based in fairfeare X. Was there for a few years, 40 00:03:01.479 --> 00:03:10.000 and after my few years in DC, I was recruited by Intel to go 41 00:03:10.080 --> 00:03:15.479 and run some special projects for them. And I was with the proper part 42 00:03:15.560 --> 00:03:21.479 of Intel, which is the microprocessor groups, for five years, working on 43 00:03:21.520 --> 00:03:25.039 a lot of different new technologies, anything from computer vision to face recognition to 44 00:03:25.120 --> 00:03:30.319 what we call big data and AI pattern recognition and the technologies like that. 45 00:03:30.599 --> 00:03:39.719 Worked on new microprocessor designs and circuit designs for those new chips. Around five 46 00:03:40.039 --> 00:03:44.080 Intel was getting into back into healthcare, and it was one of the few 47 00:03:44.360 --> 00:03:49.280 executives in the company that had any healthcare experience, and so I joined the 48 00:03:49.319 --> 00:03:53.080 new division, which was Intel dig Digital Health, and I ended up spinning 49 00:03:53.080 --> 00:03:58.080 out a company out of Intel called Dossia, the healthcare I T company, 50 00:03:58.400 --> 00:04:02.960 and Intel was investor, and the ten very large companies ended up being investors 51 00:04:02.960 --> 00:04:09.199 and supporters and customers companies like Walmart, ATNT, McKesson, and a whole 52 00:04:09.199 --> 00:04:14.319 bunch of other ones. And that sort of introduced me to the whole to 53 00:04:14.400 --> 00:04:19.279 the whole area of electronic medical records and sort of what was happening in the 54 00:04:19.399 --> 00:04:25.399 larger, larger discussions in healthcare in the country. After a few years running 55 00:04:25.399 --> 00:04:29.480 that company that was based in Boston, I went back to Intel starting a 56 00:04:29.519 --> 00:04:32.680 new business for them around genomics. That was the area next gen sequencing. 57 00:04:33.439 --> 00:04:40.480 And at that time I also started the research some research work at Harvard Medical 58 00:04:40.560 --> 00:04:46.160 School as a part time, part time faculty member, and I was being 59 00:04:46.199 --> 00:04:50.279 an entrepreneur on the site in the areas of diagnostics and genomics. And I 60 00:04:50.319 --> 00:04:55.920 haven't stopped since. I've started six companies since then. Wow, And the 61 00:04:56.000 --> 00:05:00.360 one they were talking about today in Ninidia is the sixth one. So I'm 62 00:05:00.360 --> 00:05:02.040 going to stop you right there because I'm going to fanboy just for a second, 63 00:05:02.079 --> 00:05:05.720 if you don't mind. So, between Kodak and all the other amazing 64 00:05:05.720 --> 00:05:09.519 things you've done, and I'll give you an analogy. I work in radio, 65 00:05:09.560 --> 00:05:12.600 but I played sports, and you know as well as I do that 66 00:05:12.720 --> 00:05:15.920 when people in the media or celebrities meet sports people, they want to be 67 00:05:16.040 --> 00:05:18.600 them, and the rock stars want to be the sports guys. You know, 68 00:05:18.639 --> 00:05:23.160 It's just that thing that you always admire somebody's profession, right, So 69 00:05:23.480 --> 00:05:29.160 I love photography and I also love just, you know, technology. Now 70 00:05:29.160 --> 00:05:31.360 you're inside the looking glass. I'm outside of when I hear you talk about 71 00:05:31.360 --> 00:05:34.240 all these amazing things that you've done over your career so far, and I 72 00:05:34.279 --> 00:05:40.160 know you have so much more to go. Is it amazing to you between 73 00:05:40.160 --> 00:05:44.439 the Kodak stuff and all the other things that you've done with genomes and sequencing 74 00:05:44.600 --> 00:05:46.680 and all the new technologies that are coming up in front of you? Or 75 00:05:47.240 --> 00:05:49.920 is it another day at the office. And I know I'm not being modeling 76 00:05:49.959 --> 00:05:53.519 about that. I'm just curious because you're living inside it every day, so 77 00:05:53.560 --> 00:05:56.399 it's different for you than it is for me. But is it still amazing 78 00:05:56.399 --> 00:06:00.120 that you're coming up with incredible things every day of all the things you've done, 79 00:06:00.680 --> 00:06:06.519 absolutely absolutely, and I feel very fortunate to have been to have been 80 00:06:06.560 --> 00:06:10.800 able to do that. You know, that's part of it. You know. 81 00:06:11.120 --> 00:06:15.040 I sort of choose to go into it because I'm endlessly curious about new 82 00:06:15.120 --> 00:06:19.800 things, but just having had the opportunity to be at the ground floor a 83 00:06:19.839 --> 00:06:24.759 lot of these things, I feel very fortunate. Well, that's great, 84 00:06:24.959 --> 00:06:28.800 Listen. I'm always intrigued by names of companies, especially when I'm not sure 85 00:06:28.800 --> 00:06:30.839 what exactly it means, but it catches my attention. Can you tell me 86 00:06:30.839 --> 00:06:36.560 the origin of the name of the company. Namida is Japanese for tears okay, 87 00:06:38.240 --> 00:06:42.439 and there is there is, there's more meaning behind it. So during 88 00:06:42.439 --> 00:06:44.879 the Edo period, which was sort of like this, you know, the 89 00:06:44.920 --> 00:06:50.879 Samurai, the last Samurai period in Japan. In Tokyo U, there is 90 00:06:50.959 --> 00:06:56.839 a bridge called Namida Bashi with the bridge of tiars Okay and it's the bridge 91 00:06:56.879 --> 00:07:01.639 that linked the prison to the execution ground, and that's where the condemned were 92 00:07:01.639 --> 00:07:05.959 allowed to say goodbye to their loved ones. Hence the name Bridge of tears. 93 00:07:08.639 --> 00:07:13.040 To me, cancer is similar to that bridge of tiers. It's what 94 00:07:13.480 --> 00:07:18.480 gets takes our loved ones away from us, and the mission of Namida is 95 00:07:18.560 --> 00:07:23.399 to end those tiers, to end cancer by finding it, by finding it 96 00:07:23.439 --> 00:07:26.600 early. Boy, I love that that all comes together, and that's really 97 00:07:26.600 --> 00:07:29.720 well thought of. That that's very cool. I'm glad that you shared that 98 00:07:29.759 --> 00:07:32.639 with us. All right, let's do it thirty dollars. Yes, we 99 00:07:32.720 --> 00:07:36.800 work in tiers. Tiers is our medium of testing exactly, so it has 100 00:07:36.839 --> 00:07:40.600 a double meaning, the double entendre. I really do like that a lot. 101 00:07:40.639 --> 00:07:44.279 That's very witty, So thank you for that. Okay, let's do 102 00:07:44.360 --> 00:07:46.839 this. There's going to be a lot of people that are listening to this 103 00:07:46.920 --> 00:07:50.040 interview, Omita about what exactly you do, So if you could give us 104 00:07:50.079 --> 00:07:55.279 a thirty thousand foot view about what you and your step from the company does. 105 00:07:55.319 --> 00:07:59.160 What is that we run. Essentially, we run two companies here under 106 00:07:59.160 --> 00:08:03.360 one roof. One of them is an R and D biotech company discovering new 107 00:08:03.399 --> 00:08:09.920 buyer markers to develop assays for early detection of cancers. And we also run 108 00:08:11.000 --> 00:08:15.360 a second company, which is a you know, it's a licensed laboratory to 109 00:08:15.519 --> 00:08:24.879 actually run those tests and and uh, early cancer detection is really the easiest 110 00:08:24.920 --> 00:08:31.240 way of cutting back a number of depths and cancer and cutting the cost of 111 00:08:31.720 --> 00:08:37.440 of of treatment of cancer and so early cancer detection is the goal of our 112 00:08:37.480 --> 00:08:43.799 company. And we want to bring tests that are reasonably priced so they can 113 00:08:43.840 --> 00:08:48.919 be available to everyone. And uh and that's one of the reasons that we 114 00:08:48.960 --> 00:08:54.080 are working in the medium of tiers is because tears are the shadow of blood, 115 00:08:54.720 --> 00:08:58.440 but they're all They're also highly concentrated. So if you're looking for low 116 00:08:58.480 --> 00:09:05.600 abundance, it's small molecules that that can that that can denote presence of cancer 117 00:09:05.600 --> 00:09:11.399 in your body. You can find them much easier, which means a much 118 00:09:11.519 --> 00:09:16.120 less expensive test in tears than you can say in blood. All right, 119 00:09:16.240 --> 00:09:20.519 so I'm fascinated and got me hooked. And I'm sure O listeners are now 120 00:09:20.519 --> 00:09:24.600 about a little specificity about what you do. So before you started this company, 121 00:09:24.679 --> 00:09:28.320 what was available for cancer screening and how have you changed the industry with 122 00:09:28.360 --> 00:09:33.440 this new company in Namida. So for cancer screening depends what type of cancer. 123 00:09:33.519 --> 00:09:37.240 So we have one product not called Aria and it's been in the market 124 00:09:37.279 --> 00:09:43.559 for by nine months as a direct to consumer test, and ARIA is a 125 00:09:43.559 --> 00:09:50.399 breast cancer screening test. So you so breast cancer screening is probably one of 126 00:09:50.440 --> 00:09:56.840 the most well publicized cancers. And you know, in the October everyone where's 127 00:09:56.879 --> 00:10:01.279 pink, there's there's you know, there's a there's a lot of not for 128 00:10:01.360 --> 00:10:05.440 profits that sort of like remind people that this is the month that you should 129 00:10:05.440 --> 00:10:11.240 go get you get a mammogram. So mimmography is a technology that sort of 130 00:10:11.320 --> 00:10:16.600 established itself in mid nineteen eighties. And I can give you a little historical 131 00:10:18.519 --> 00:10:24.759 you know, actually probably the best, the best historically documented cancer is breast 132 00:10:24.759 --> 00:10:30.200 cancer. The very first breast cancer was a Tusa, daughter of Cyrus, 133 00:10:31.120 --> 00:10:37.440 Cyrus the liberator of Jews from Babylon. This was recorded in Herodotus histories that 134 00:10:37.559 --> 00:10:43.960 she had a lump in her breast and the Greek surgeon removed the lump and 135 00:10:43.039 --> 00:10:46.679 saved her life. So that is the very first case of breast cancer that 136 00:10:48.360 --> 00:10:52.759 was recorded in history. So from that fifth century BC to about nineteen eighty 137 00:10:52.799 --> 00:10:58.480 five, there was really nothing other than waiting for that lump to appear something 138 00:10:58.519 --> 00:11:03.559 that you could feel with your finger doing a self exam or a doctor doing 139 00:11:03.600 --> 00:11:09.200 an exam. And in nineteen eighties Kodak invented a much higher resolution X ray 140 00:11:09.320 --> 00:11:15.240 film and that was the birth of mimmography. So we had nothing to about 141 00:11:15.320 --> 00:11:18.200 mid nineteen eighties, and then this new X ray film gave us a tool 142 00:11:18.919 --> 00:11:24.360 that was better than nothing. It wasn't perfect, and it's still not perfect, 143 00:11:24.360 --> 00:11:28.159 but it was better than nothing. So from that mid nineteen eighties to 144 00:11:28.159 --> 00:11:31.000 today, that is pretty much the tool that we're using, and then we 145 00:11:31.080 --> 00:11:35.200 have added other imaging tests for it. Now, the problem with just using 146 00:11:35.279 --> 00:11:39.679 imaging as your first line of screening is that you've got to see a lot 147 00:11:39.720 --> 00:11:43.559 of things that are not cancer, and you're going to miss a lot of 148 00:11:43.600 --> 00:11:52.799 cancers because imaging depends on the physiology of the body. So women fifty percent 149 00:11:52.840 --> 00:11:56.279 of women in the US have what's called dense breasts, and those dense breasts 150 00:11:56.799 --> 00:12:03.759 show as white in x RA, and that that hides the calcifications that denote 151 00:12:05.000 --> 00:12:09.240 presence of breast cancer, for example. So a lot of those cancers are 152 00:12:09.279 --> 00:12:11.720 missed in women with dance press and that is a really real, big problem, 153 00:12:13.200 --> 00:12:16.480 one that has been publicized in the media, and it's been it's been 154 00:12:18.080 --> 00:12:24.200 it's been the subject of conversations in among lawmakers at the state level, at 155 00:12:24.200 --> 00:12:28.679 the federal level. But what to do about that, and so fifty percent 156 00:12:28.759 --> 00:12:33.559 of women that have dance rests are served poorly with this. Another thing that's 157 00:12:33.600 --> 00:12:39.120 been happening in the last thirty years is that we have focused screening in the 158 00:12:39.279 --> 00:12:45.720 US on women between the ages of fifty and seventy, and today, you 159 00:12:45.759 --> 00:12:50.080 know, there's a there's a proposal that's that we want to bring it down 160 00:12:50.120 --> 00:12:54.840 to forty. A lot of insurance companies already cover screening at forty. But 161 00:12:54.960 --> 00:12:58.879 what has happened is that that window of cancers in the last thirty years have 162 00:13:00.080 --> 00:13:05.519 move to younger and younger populations. So today half the mortality of breast cancer 163 00:13:05.679 --> 00:13:09.000 is in women under the age of forty five. Wow, And many of 164 00:13:09.000 --> 00:13:13.840 those women do not screen at all. Women in their thirties don't screen at 165 00:13:13.879 --> 00:13:18.840 all, so there is no tool available for them. If you're a woman 166 00:13:18.159 --> 00:13:20.840 age thirty five and you go to a doctor and say I want to ammagram, 167 00:13:22.159 --> 00:13:26.000 they will not give it to you. There's nothing available for them. 168 00:13:26.559 --> 00:13:33.120 Our tool area uses protein biomarkers found in tears and it screens for breast cancer. 169 00:13:33.559 --> 00:13:37.679 And our screening starts at age thirty because when we developed our tests, 170 00:13:39.679 --> 00:13:43.320 the data set that we use the women that we use to develop the test 171 00:13:43.639 --> 00:13:48.039 started at age thirty, so we can offer our test to women starting at 172 00:13:48.080 --> 00:13:52.120 age thirty. Now, well you mentioned this, but I know that nothing 173 00:13:52.159 --> 00:13:56.200 is perfect, but this seems like amazing revolutionary technology that you also want to 174 00:13:56.200 --> 00:14:01.200 make affordable and that healthcare covers as well. With that said, with your 175 00:14:01.600 --> 00:14:05.799 researchers and scientists and then all the doctors that you work with, I imagine 176 00:14:05.840 --> 00:14:11.120 that the medical industry is just giddy with this new technology that is starting to 177 00:14:11.120 --> 00:14:16.000 become widely available in the United States. It's it must be just wonderful that, 178 00:14:16.240 --> 00:14:18.000 you know, to make the doctors happy that they have something new that 179 00:14:18.039 --> 00:14:24.080 they can work with it to take something very quickly. Well, the small 180 00:14:24.120 --> 00:14:26.240 group of physicians that we're working with, of course they're very happy with it. 181 00:14:26.519 --> 00:14:31.159 But we're new, we're new in the market, and it takes a 182 00:14:31.200 --> 00:14:35.559 lot of I mean, the US healthcare system is very slow to adopt new 183 00:14:35.600 --> 00:14:39.440 things, right and partially because it's it's it's not centralized at all. I 184 00:14:39.440 --> 00:14:45.799 mean, you're dealing with many, many different entities, and so we're working 185 00:14:45.840 --> 00:14:50.039 our way through that through this large effort. Look with the efforts like what 186 00:14:50.080 --> 00:14:52.279 we're doing today, you know, talking talking to you, hopefully we can 187 00:14:52.320 --> 00:15:00.120 reach a few people. But who's really happy with the introduction of this this 188 00:15:00.120 --> 00:15:05.000 this tool right now it's offered as a direct to consumer test. Are women, 189 00:15:05.360 --> 00:15:09.879 women who were poorly served before who are looking for yet you know, 190 00:15:09.919 --> 00:15:16.159 they're looking for another tool and what's available to them for screening. And those 191 00:15:16.200 --> 00:15:20.639 are the ones who are happy, I imagine. So you know the other 192 00:15:20.679 --> 00:15:24.200 thing with what you do, I mean with your great staff that you have 193 00:15:24.360 --> 00:15:28.960 here and coming up with this new technology that I know, it's always fluid 194 00:15:28.240 --> 00:15:31.840 and new things are happening, and I imagine you being a visionary and an 195 00:15:31.960 --> 00:15:35.720 entrepreneur and an invenor, you're always looking down the road. I know some 196 00:15:35.799 --> 00:15:39.759 things you can predict. But what's the plan for you and the company over 197 00:15:39.799 --> 00:15:43.159 the next five years in your growth. Where we want to be is that 198 00:15:43.200 --> 00:15:48.960 we can actually take one test for many cancers. So we have six other 199 00:15:50.120 --> 00:15:52.919 R and D projects in the pipeline. So we're working on a second version 200 00:15:52.960 --> 00:16:00.799 of our breast cancer test that's a diagnostic and a diagnostic test and screening test 201 00:16:00.879 --> 00:16:04.120 for five other cancers. We've taken the biggest you know, the biggest ones 202 00:16:04.159 --> 00:16:12.519 collorectal cancer, prostate melanoma, ovarian, and pancreatic, and we have we 203 00:16:12.600 --> 00:16:18.360 have R and D projects in those five developing those five other tests. So 204 00:16:18.480 --> 00:16:22.039 five years down the road, we're hoping that we can offer suites of tests 205 00:16:22.559 --> 00:16:27.360 that are easily, easily accessible and inexpensive to everyone. Wow, I got 206 00:16:27.360 --> 00:16:30.759 to tell you the extraordinary that you're doing this, you know, because as 207 00:16:30.759 --> 00:16:33.799 I mentioned off the top of our interview, everybody's been touched by cancer, 208 00:16:33.320 --> 00:16:37.279 UH in a very poor way, whether it's yourself or a family member or 209 00:16:37.279 --> 00:16:41.919 a friend or somebody that you know, including you know, my dad died 210 00:16:41.919 --> 00:16:45.320 of lung cancer, and my mother in law has had breast cancer, and 211 00:16:45.360 --> 00:16:48.000 I've had friends that have gone through some rough outs with cancer. I luckily 212 00:16:48.000 --> 00:16:52.720 have not lost anybody for a very long long time. UH. Medical scientists 213 00:16:52.720 --> 00:16:56.159 getting better. But thanks to you and your team and companies, this just 214 00:16:56.200 --> 00:17:00.480 seems revolutionary, very exciting. So let's this media as we kind of wrap 215 00:17:00.600 --> 00:17:06.279 up, maybe i'd like to have you give our listener just one more takeaway 216 00:17:06.400 --> 00:17:10.359 about your company, the things you're doing, and just maybe some final thoughts 217 00:17:10.359 --> 00:17:14.440 from you about what you want them to know about when it comes to NEMIDA. 218 00:17:14.519 --> 00:17:18.000 What's unique about NEMIDA is that we use tiers as our medium of testing, 219 00:17:18.839 --> 00:17:23.680 and and tiars being a shadow of blood. There are it's they're full 220 00:17:23.680 --> 00:17:30.400 of bar markers. There are protein bar markers, RNA, DNA, misoblomic 221 00:17:30.519 --> 00:17:34.880 data. There's a lot of data in there. And and because they're so 222 00:17:36.039 --> 00:17:41.599 easily accessible that you can you can collect tiers within three minutes at home or 223 00:17:41.640 --> 00:17:48.359 in the doctor's office or any other place, and you can you can make 224 00:17:48.400 --> 00:17:53.480 inexpensive tests that is accessible to everyone. And and going down the road, 225 00:17:53.599 --> 00:17:57.880 there's going to be so many of these new sensors and new ways of detecting 226 00:17:57.960 --> 00:18:04.000 things that hopefully we can make cancer not the death sentence that it was that 227 00:18:04.079 --> 00:18:10.119 it is today for for a percentage of people get it, but actually can 228 00:18:10.160 --> 00:18:15.400 make it something like that's easily treatable and found in very early stages. I 229 00:18:15.359 --> 00:18:18.440 I mean, if somebody wants to just get educated a little bit more on 230 00:18:18.440 --> 00:18:22.079 what exactly you do with the media lab and your staff and all the things 231 00:18:22.079 --> 00:18:25.960 that are coming up, which is just terribly exciting. This has just been 232 00:18:26.000 --> 00:18:29.799 thrilling to talk about. What's the website that they can check out namedia lab 233 00:18:30.359 --> 00:18:34.279 N A M I D A L A b dot com is our website and 234 00:18:34.440 --> 00:18:37.440 our product. If you want to learn more about our breast cancer products, 235 00:18:37.519 --> 00:18:42.960 you can find that at ari EA dot care au r I A dot C 236 00:18:44.000 --> 00:18:45.839 A R E. Well, I can't tell you how much I appreciate your 237 00:18:45.839 --> 00:18:48.880 time. I could talk to hours about this because I've just as I said 238 00:18:48.880 --> 00:18:53.000 earlier, I'm fanboing out with all the incredible things you've done over your lifetime, 239 00:18:53.039 --> 00:18:56.000 and I know there's more work to done to do, but you know, 240 00:18:56.119 --> 00:19:00.039 making a difference in people's lives and keeping them alive for a lot longer 241 00:19:00.519 --> 00:19:03.680 than they have in the past is just an extraordinary gift that I know. 242 00:19:03.839 --> 00:19:07.480 This is something that I'm sure you and your staff cherish, but just hearing 243 00:19:07.519 --> 00:19:11.000 about it and listening to all the amazing things you're doing, I'm just thrilled 244 00:19:11.319 --> 00:19:15.079 that you came up with this company five years ago you're executing it. I 245 00:19:15.119 --> 00:19:18.799 know it's you have to be patient, but it's just incredible what you do, 246 00:19:18.839 --> 00:19:22.480 and I just want to watch you continue success and thank you so much 247 00:19:22.480 --> 00:19:25.920 for joining us on CEOs. You should know thank you, Dennis, appreciate it.